
Loading, please wait...

Loading, please wait...

Peroral endoscopic myotomy (POEM) has emerged as a cornerstone treatment for achalasia. However, confirming clinical success post-operatively is essential for long-term management. Recent research highlights how high-resolution impedance manometry (HRiM) compares to the traditional timed barium esophagram (TBE) in assessing esophageal clearance. The study analyzed 103 patients who underwent POEM and followed them for one year. Overall, the clinical success rate reached 90% at the end of the follow-up period.
Notably, both diagnostic tools showed significant improvement in esophageal clearance following the procedure. However, the specificity of high-resolution impedance manometry was considerably higher than that of barium studies. Specifically, impedance manometry demonstrated a specificity of 82%, while the esophagram showed only 59%. Furthermore, any residual bolus detected by impedance at three months predicted treatment failure at one year. Similarly, a barium bolus height of 9 cm served as a meaningful threshold for TBE. Therefore, this technology provides clinicians with a highly reproducible and reliable method for post-operative monitoring.
The high negative predictive value of 95% makes impedance a powerful tool to rule out treatment failure. Because HRiM assesses both esophageal motility and clearance simultaneously, it may reduce the need for multiple diagnostic tests. Consequently, surgeons and gastroenterologists can streamline the follow-up process. Future guidelines may incorporate these specific thresholds to improve patient outcomes in achalasia management.
High-resolution impedance manometry incorporates impedance sensors alongside traditional pressure sensors. This addition allows the device to track the movement of boluses through the esophagus in real-time. Therefore, it provides objective information on both motor function and the physical clearance of liquids.
Research indicates that any residual bolus detected via HRiM at three months post-procedure is a meaningful predictor of long-term failure. For timed barium esophagrams, a bolus height greater than 9 cm at the three-mark serves as the primary predictive threshold.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Berger A et al. Esophageal clearance assessed by high-resolution impedance manometry in achalasia: a prospective study with 1-year follow-up. Am J Gastroenterol. 2026 May 26. doi: 10.14309/ajg.0000000000004066. PMID: 42189589.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective study validates HRiM as a reliable tool for assessing esophageal clearance and predicting success 1 year after POEM in achalasia patients....
4 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today